$1.06B
Revenue
$-1.25B
Net Income
82.43%
Gross Margin
-122.23%
Op. Margin
$246.24M
Free Cash Flow
| Breakdown | FY 2025 (Dec 31, 2025) |
|---|---|
| Total Revenue | $1.06B |
| Revenue Growth % | nan% |
| Cost of Revenue | $185.53M |
| Gross Profit | $870.26M |
| Gross Margin % | 82.4% |
| Operating Expenses | $2.16B |
| Research & Development | $1.03B |
| Operating Income | $-1.29B |
| Operating Margin % | -122.2% |
| Other Income/Expense | $64.81M |
| Income Before Tax | $-1.23B |
| Income Tax Expense | $24.82M |
| Net Income | $-1.25B |
| Net Margin % | -118.4% |
| Basic EPS | -3.71 |
| Diluted EPS | -3.71 |
| Basic Shares Outstanding | 337.0M |
| Diluted Shares Outstanding | 337.0M |
| Breakdown | FY 2025 (Dec 31, 2025) |
|---|---|
| Cash & Cash Equivalents | $403.47M |
| Short-term Investments | $1.25B |
| Accounts Receivable | $247.91M |
| Other Current Assets | $85.27M |
| Total Current Assets | $2.00B |
| Property Plant & Equipment | $20.00M |
| Goodwill | $101.40M |
| Intangible Assets | $19.08M |
| Other Non-current Assets | $120.71M |
| Total Assets | $2.35B |
| Accounts Payable | $4.50M |
| Accrued Liabilities | $66.53M |
| Deferred Revenue | $595.33M |
| Other Current Liabilities | $31.83M |
| Total Current Liabilities | $776.11M |
| Other Non-current Liabilities | $5.62M |
| Total Liabilities | $837.57M |
| Retained Earnings | $-1.44B |
| Total Stockholders Equity | $1.51B |
| Total Liabilities & Equity | $2.35B |
| Breakdown | FY 2025 (Dec 31, 2025) |
|---|---|
| Net Income | $-1.25B |
| Depreciation & Amortization | $15.59M |
| Stock-based Compensation | $1.36B |
| Deferred Income Tax | $-2.14M |
| Change in Receivables | $117.72M |
| Change in Payables | $154.00K |
| Operating Cash Flow | $250.68M |
| Capital Expenditure | $4.44M |
| Acquisitions | $58.34M |
| Purchases of Investments | $1.25B |
| Sales of Investments | $839.54M |
| Investing Cash Flow | $-371.41M |
| Financing Cash Flow | $43.34M |
| Net Change in Cash | $-77.39M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $274.17M | $198.64M | $752.01M | $532.07M |
| Cost of Revenue | $83.88M | $18.70M | $131.22M | $71.05M |
| Gross Profit | $190.29M | $179.94M | $620.79M | $461.01M |
| Operating Expenses | $1.33B | $227.27M | $1.72B | $1.39B |
| Research & Development | $680.88M | $104.18M | $833.86M | $692.57M |
| Operating Income | $-1.14B | $-47.34M | $-1.09B | $-929.10M |
| Other Income/Expense | $29.30M | $17.91M | $73.56M | $45.23M |
| Income Before Tax | $-1.11B | $-29.43M | $-1.02B | $-883.87M |
| Income Tax Expense | $-10.46M | $-13.83M | $2.51M | $-53.94M |
| Net Income | $-1.10B | $-15.60M | $-1.02B | $-829.93M |
| Basic EPS | -2.72 | -0.07 | -3.68 | -4.37 |
| Diluted EPS | -2.72 | -0.07 | -3.68 | -4.37 |
| Basic Shares Outstanding | $403.21M | $210.77M | $278.41M | $190.06M |
| Diluted Shares Outstanding | $403.21M | $210.77M | $278.41M | $190.06M |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $340.49M | $486.95M |
| Short-term Investments | $1.24B | $970.88M |
| Accounts Receivable | $156.00M | $131.31M |
| Other Current Assets | $79.90M | $48.87M |
| Total Current Assets | $1.84B | $1.64B |
| Property Plant & Equipment | $17.95M | $15.02M |
| Goodwill | $24.54M | $11.40M |
| Intangible Assets | $16.04M | $2.51M |
| Other Non-current Assets | $100.41M | $93.76M |
| Total Assets | $2.07B | $1.79B |
| Accounts Payable | $13.36M | $4.16M |
| Accrued Liabilities | $51.84M | $31.12M |
| Deferred Revenue | $473.57M | $381.36M |
| Total Current Liabilities | $622.48M | $446.96M |
| Other Non-current Liabilities | $5.67M | $4.30M |
| Total Liabilities | $684.71M | $469.10M |
| Retained Earnings | $-1.22B | $-192.91M |
| Total Stockholders Equity | $1.39B | $1.32B |
| Total Liabilities & Equity | $2.07B | $1.79B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-1.10B | $-15.60M | $-1.02B | $-829.93M |
| Depreciation & Amortization | - | - | $9.54M | $6.11M |
| Stock-based Compensation | - | - | $1.15B | $947.40M |
| Change in Receivables | - | - | $25.53M | $7.35M |
| Change in Payables | - | - | $6.08M | $434.00K |
| Operating Cash Flow | - | - | $210.79M | $-134.81M |
| Capital Expenditure | - | - | $3.71M | $1.31M |
| Acquisitions | - | - | $21.00M | - |
| Purchases of Investments | - | - | $1.01B | $1.07B |
| Sales of Investments | - | - | $671.55M | $306.86M |
| Investing Cash Flow | - | - | $-294.45M | $-720.79M |
| Stock Issued | - | - | - | $418.97M |
| Stock Repurchased | - | - | - | $861.00K |
| Financing Cash Flow | - | - | $-55.67M | $1.24M |
| Net Change in Cash | - | - | $-139.32M | $-854.36M |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.